Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. (Q53661231)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 March 2015

edit

Language	Label	Description	Also known as
English	Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.	scientific article published on 5 March 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

title

Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

main subject

type 2 diabetes

0 references

author

Kenichi Ohashi

series ordinal

14

object named as

Kenichi Ohashi

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

author name string

Koki Mise

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Junichi Hoshino

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Toshiharu Ueno

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Ryo Hazue

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Keiichi Sumida

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Rikako Hiramatsu

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Eiko Hasegawa

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Masayuki Yamanouchi

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Noriko Hayami

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Tatsuya Suwabe

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Naoki Sawa

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Takeshi Fujii

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Shigeko Hara

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Kenmei Takaichi

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Yoshifumi Ubara

series ordinal

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

publication date

5 March 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

published in

Diabetes - Metabolism: Research and Reviews

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

volume

31

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

page(s)

572-581

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

cites work

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Clinical impact of albuminuria in diabetic nephropathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Early renal function decline in type 2 diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Pathologic classification of diabetic nephropathy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Metabolic memory: mechanisms and implications for diabetic retinopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Statistical methods for assessment of added usefulness of new biomarkers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

The modern spectrum of renal biopsy findings in patients with diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

21 January 2018

Homocysteine and reclassification of cardiovascular disease risk

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FDMRR.2633

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/DMRR.2633

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

Fatcat ID

release_geyk35vqird6llbl2v6amwjtg4

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/geyk35vqird6llbl2v6amwjtg4

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

25533683

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25533683

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/25533683

ResearchGate publication ID

269999905

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53661231&oldid=1836247591"